摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diethyl [5-acetamido-4-azido-6-(1,2,3-triacetoxy)propyl-4,5,6-trihydropyran-2-yl]phosphonate | 1338226-30-4

中文名称
——
中文别名
——
英文名称
diethyl [5-acetamido-4-azido-6-(1,2,3-triacetoxy)propyl-4,5,6-trihydropyran-2-yl]phosphonate
英文别名
[(2R,3S)-3-[(2R,3R,4S)-3-acetamido-4-azido-6-diethoxyphosphoryl-3,4-dihydro-2H-pyran-2-yl]-2,3-diacetyloxypropyl] acetate
diethyl [5-acetamido-4-azido-6-(1,2,3-triacetoxy)propyl-4,5,6-trihydropyran-2-yl]phosphonate化学式
CAS
1338226-30-4
化学式
C20H31N4O11P
mdl
——
分子量
534.46
InChiKey
CCHXADBRYUCNHV-APQLOABGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    36
  • 可旋转键数:
    16
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    167
  • 氢给体数:
    1
  • 氢受体数:
    13

反应信息

  • 作为反应物:
    描述:
    diethyl [5-acetamido-4-azido-6-(1,2,3-triacetoxy)propyl-4,5,6-trihydropyran-2-yl]phosphonate氢气 作用下, 以 乙醇 为溶剂, 反应 5.0h, 以278 mg的产率得到[(2R,3S)-3-[(2R,3R,4S)-3-acetamido-4-amino-6-diethoxyphosphoryl-3,4-dihydro-2H-pyran-2-yl]-2,3-diacetyloxypropyl] acetate
    参考文献:
    名称:
    A Practical Synthesis of Zanamivir Phosphonate Congeners with Potent Anti-influenza Activity
    摘要:
    Two phosphonate compounds la (4-amino-1-phosphono-DANA) and 1b (phosphono-zanamivir) are synthesized and shown More potent than zanamivir against the neuraminidases of avian and human influenza viruses, including the oseltamivir-resistant strains. For the first time, the practical synthesis of these phosphonate compounds is realized by conversion of sialic acid to peracetylated phosphono-DANA diethyl ester (5) as a key intermediate in three steps by a novel approach. In comparison with zanamivir, the high affinity of la and 1b can be partly attributable to the strong electrostatic interactions of their phosphonate,group'S With the three arginine residues (Arg118, Arg292, and Arg371) in the active site of neuraminidases. These phosphonates are nontoxic to the human 293T cells; they protect cells from influenza : virus infection with EC50 values. in low-nanomolar range; including the wild-type WSN (H1N1), the 2009 pandemic (H1N1), the oseltamivir-resistant H274Y (H1N1), RG14 (H5N1); and Udorn (H3N2) influenza strains.
    DOI:
    10.1021/ja207892q
  • 作为产物:
    参考文献:
    名称:
    A Practical Synthesis of Zanamivir Phosphonate Congeners with Potent Anti-influenza Activity
    摘要:
    Two phosphonate compounds la (4-amino-1-phosphono-DANA) and 1b (phosphono-zanamivir) are synthesized and shown More potent than zanamivir against the neuraminidases of avian and human influenza viruses, including the oseltamivir-resistant strains. For the first time, the practical synthesis of these phosphonate compounds is realized by conversion of sialic acid to peracetylated phosphono-DANA diethyl ester (5) as a key intermediate in three steps by a novel approach. In comparison with zanamivir, the high affinity of la and 1b can be partly attributable to the strong electrostatic interactions of their phosphonate,group'S With the three arginine residues (Arg118, Arg292, and Arg371) in the active site of neuraminidases. These phosphonates are nontoxic to the human 293T cells; they protect cells from influenza : virus infection with EC50 values. in low-nanomolar range; including the wild-type WSN (H1N1), the 2009 pandemic (H1N1), the oseltamivir-resistant H274Y (H1N1), RG14 (H5N1); and Udorn (H3N2) influenza strains.
    DOI:
    10.1021/ja207892q
点击查看最新优质反应信息

文献信息

  • ZANAMIVIR PHOSPHONATE CONGENERS WITH ANTI-INFLUENZA ACTIVITY AND DETERMINING OSELTAMIVIR SUSCEPTIBILITY OF INFLUENZA VIRUSES
    申请人:Wong Chi-Huey
    公开号:US20130225532A1
    公开(公告)日:2013-08-29
    Methods and compositions for detection of drug resistant pathogens and treatment against infections thereof are provided. Methods for detection of oseltamivir-resistant influenza viruses by competitive binding assays utilizing non-oseltamivir influenza virus neuraminidase inhibitors and oseltamivir carboxylate are provided. Influenza virus neuraminidase inhibitors coupled to sensors and useful for employment in the methods of the invention are disclosed. Novel phosphonate compounds active as neuraminidase inhibitors against wild-type and oseltamivir-resistant influenza strains of H1N1, H5N1 and H3N2 viruses are disclosed. An enantioselective synthetic route to preparation of these phosphonate compounds via sialic acid is provided.
    本发明提供了检测耐药病原体和治疗感染的方法和组合物。本发明提供了利用非奥司他韦流感病毒神经氨酸酶抑制剂奥司他韦羧酸盐进行竞争结合测定的检测奥司他韦耐药性流感病毒的方法。本发明还揭示了与传感器耦合并在本发明方法中使用的流感病毒神经氨酸酶抑制剂。本发明还揭示了对H1N1、H5N1和H3N2病毒的野生型和奥司他韦耐药株具有神经氨酸酶抑制剂活性的新型膦酸酯化合物。本发明还提供了通过唾液酸的对映选择性合成途径制备这些膦酸酯化合物的方法。
  • ZANAMIVIR PHOSPHONATE CONGENERS WITH ANTI-INFLUENZA ACTIVITY AND DETERMINING OSELTAMIVIR SUSCEPTIBILITY OF INFLUENZA VIRUSES
    申请人:Academia Sinica
    公开号:EP2975409A1
    公开(公告)日:2016-01-20
    Methods and compositions for detection of drug resistant pathogens and treatment against infections thereof are provided. Methods for detection of oseltamivir-resistant influenza viruses by competitive binding assays utilizing non-oseltamivir influenza virus neuraminidase inhibitors and oseltamivir carboxylate are provided. Influenza virus neuraminidase inhibitors coupled to sensors and useful for employment in the methods of the invention are disclosed. Novel phosphonate compounds active as neuraminidase inhibitors against wild-type and oseltamivir-resistant influenza strains of H1N1, H5N1 and H3N2 viruses are disclosed. An enantioselective synthetic route to preparation of these phosphonate compounds via sialic acid is provided.
    提供了检测耐药病原体和治疗其感染的方法和组合物。本发明提供了通过利用非奥司他韦流感病毒神经氨酸酶抑制剂奥司他韦羧酸盐的竞争性结合测定来检测抗奥司他韦流感病毒的方法。本发明公开了与传感器结合并可用于本发明方法的流感病毒神经氨酸酶抑制剂。本发明公开了新型膦酸盐化合物,作为神经氨酸酶抑制剂对野生型和抗奥司他韦的 H1N1、H5N1 和 H3N2 流感病毒株具有活性。本发明提供了通过硅烷酸制备这些膦酸盐化合物的对映体选择性合成路线。
  • US9403855B2
    申请人:——
    公开号:US9403855B2
    公开(公告)日:2016-08-02
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-3-BOC-5-甲基-1,2,3-氧杂噻唑烷-2,2-二氧化物 (R)-2-苯基-3-羟基丙酸 (R)-2-羟基-2-(2-(2-(2-甲氧基-5-甲基吡啶-3-基)乙基)-琥珀酸 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4S)-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S)-4-i-丙基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (4R)-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S,3R)-2,3-二羟基-3-(2-吡啶基)丙酸乙酯,N-氧化物 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (2-三甲基甲硅烷基)-乙氧基甲基三氟硼酸钾 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 (11bR,11''bR)-2,2''-[氧双(亚甲基)]双[4-羟基-4,4''-二氧化物-二萘并[2,1-d:1'',2''-f][1,3,2]二氧磷杂七环 (11aR)-10,11,12,13-四氢-5-羟基-3,7-二-1-萘-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂磷杂八环 (1-氨基丁基)磷酸 (-)-N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸甲酯 齐特巴坦